Casandra
Casandra Test Code QD94627Version 1 (DRAFT)
Performing Lab
NF1 Sequencing and Deletion/Duplication
Also known as: Neurofibromatosis
Clinical Use
Order TestUse
This test is used to identify individuals with autosomal dominant neurofibromatosis type 1 (NF1) syndrome by detecting single‑nucleotide variants, deletions, and duplications in the NF1 gene, which encodes the neurofibromin protein. It supports diagnosis in individuals who meet clinical criteria or in young children with only partial features, and can confirm familial mutations when present.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
NGS (Targeted)
Biomarkers
NF1
GeneSNV/Indel • Mutation • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Related Tests
Other tests from different labs that may be relevant
Neurofibromatosis 1
Ambry Genetics
Neurofibromatosis Type 1, NF1, Full Gene Analysis, Varies
Mayo Clinic Lab
Neurofibromatosis Type 1 and Legius Syndrome Panel, Sequencing and Deletion/Duplication
ARUP Laboratories
NF1 Panel
GeneDx
Neurofibromatosis Type 1 (NF1) and Legius Syndrome Panel
Prevention Genetics
Invitae NF1-related Conditions Test
Invitae Corporation
FBN1 Gene Sequencing + Deletion/Duplication
GeneDx
FBN1 Full Gene Sequencing with Deletion/Duplication, Varies
Mayo Clinic Lab
Invitae NF2-related Schwannomatosis Test
Invitae Corporation
NF2 Panel
GeneDx
